Ganciclovir Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ganciclovir
A
- abacavir / lamivudine / zidovudine
- Abecma (idecabtagene vicleucel)
- Abelcet (amphotericin b lipid complex)
- abemaciclib
- abiraterone / niraparib
- Abraxane (paclitaxel protein-bound)
- Abrilada (adalimumab)
- acalabrutinib
- AccessPak for HIV PEP Basic (emtricitabine / tenofovir)
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir)
- AccessPak for HIV PEP Expanded with Viracept (emtricitabine / nelfinavir / tenofovir)
- Actimmune (interferon gamma-1b)
- adalimumab
- Adcetris (brentuximab)
- adefovir
- Adriamycin (doxorubicin)
- Adriamycin PFS (doxorubicin)
- Adriamycin RDF (doxorubicin)
- Adrucil (fluorouracil)
- AK-Chlor (chloramphenicol ophthalmic)
- Akeega (abiraterone / niraparib)
- albendazole
- Albenza (albendazole)
- aldesleukin
- alemtuzumab
- Alimta (pemetrexed)
- Aliqopa (copanlisib)
- Alkeran (melphalan)
- altretamine
- AmBisome (amphotericin b liposomal)
- Amjevita (adalimumab)
- Amphocin (amphotericin b)
- Amphotec (amphotericin b cholesteryl sulfate)
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- ampicillin / probenecid
- Amtagvi (lifileucel)
- Ancobon (flucytosine)
- Arava (leflunomide)
- Arranon (nelarabine)
- Arzerra (ofatumumab)
- asciminib
- asparaginase escherichia coli
- Astagraf XL (tacrolimus)
- Atripla (efavirenz / emtricitabine / tenofovir)
- Aubagio (teriflunomide)
- auranofin
- Aurolate (gold sodium thiomalate)
- aurothioglucose
- avapritinib
- Avsola (infliximab)
- axicabtagene ciloleucel
- Ayvakit (avapritinib)
- azacitidine
- Azasan (azathioprine)
- azathioprine
- Azedra (iobenguane I 131)
More about ganciclovir
- ganciclovir consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: purine nucleosides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.